Philogen S.p.A.

Neoadjuvant cancer immunotherapy is poised to advance in 2025 and beyond, giving hope that in the future patients could be cured early, perhaps escaping debilitating surgeries. For biopharma companies

Leading Indian companies such as Dr Reddy’s Laboratories, Sun Pharma and Cipla have deployed distinct strategic approaches to drive their business in China, a tough market to crack by any yardstick bu

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Shionogi Gets Daridorexant’s Japanese D

The European Medicines Agency has begun fast-track reviews of the EU marketing applications for sipavibart, AstraZeneca ’s drug for preventing COVID-19 in immunocompromised patients, and dorocubicel,